FDA approves new drug for Alzheimer's
Russ Paulsen, the Chief Operating Officer of UsAgainstAlzheimer's, talks about a new drug called Aducanumab for Alzheimer's treatment.
Russ Paulsen, the Chief Operating Officer of UsAgainstAlzheimer's, talks about a new drug called Aducanumab for Alzheimer's treatment.